The United States Food and Drug Administration (FDA) is introducing the Digital Health Center of Excellence within the Center for Devices and Radiological Health (CDRH), it was reported on Tuesday.
The US FDA is to continue to build and formalise the coordinating structure and operation of the Digital Health Center of Excellence under its effort to modernise digital health policies and regulatory approaches.
The FDA is naming Bakul Patel as the first director. He has been leading regulatory and scientific efforts related to digital health devices at the US FDA since 2010.
Foresee Pharmaceuticals receives positive CHMP opinion for CAMCEVI 21 mg
Great Novel Therapeutics' GNTbm-38 approved by US FDA for Phase I trial
Johnson & Johnson reports US FDA approval of TECVAYLI plus DARZALEX FASPRO for RRMM
Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation
Sanaregen receives FDA clearance for retinal degeneration clinical trial
Esperion to acquire Corstasis, expanding cardiovascular portfolio
ReviR Therapeutics doses first participant in First-in-Human Phase 1 clinical trial of RTX-117
BD receives FDA clearance for Surgiphor 1000mL irrigation system
United Therapeutics' ralinepag reduces risk of clinical worsening in pivotal PAH study